Literature DB >> 20125013

Mechanisms of action of antiepileptic drugs: the search for synergy.

Carl E Stafstrom1.   

Abstract

PURPOSE OF REVIEW: The aim is to review rational polytherapy of antiepileptic drugs in terms of conventional and novel mechanisms of action, consider combinations that might be beneficial when used as polytherapy, and discuss whether animal models can predict clinical efficacy. RECENT
FINDINGS: Many patients with epilepsy require concurrent treatment with more than one antiepileptic drug (rational polytherapy), but there is little information available as to which drugs might work best in combination. Conventional antiepileptic drugs act by blocking sodium channels or enhancing gamma-aminobutyric acid function. Some newer antiepileptic drugs have novel mechanisms of action, including impairment of the slow inactivation of sodium channels, binding to the presynaptic vesicle protein SV2A, binding to the calcium channel alpha2delta subunit, and opening select potassium channels. Several antiepileptic drugs have multiple or uncertain mechanisms of action. Quantitative techniques such as isobolography can be used to compare the efficacy and side effects of antiepileptic drug combinations in animals. However, neither such methods nor antiepileptic drug mechanisms of action have yet proven useful in predicting clinical benefit in patients.
SUMMARY: Animal models can be used to help predict drug combinations that might be effective clinically, based on novel mechanisms of action. However, at this point, antiepileptic drug choice in patients with epilepsy remains empirical.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20125013     DOI: 10.1097/WCO.0b013e32833735b5

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  20 in total

1.  A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.

Authors:  John-Kenneth Sake; David Hebert; Jouko Isojärvi; Pamela Doty; Marc De Backer; Kendra Davies; Andrea Eggert-Formella; James Zackheim
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

2.  Antiseizure drugs differentially modulate θ-burst induced long-term potentiation in C57BL/6 mice.

Authors:  Peter J West; Gerald W Saunders; Gregory J Remigio; Karen S Wilcox; H Steve White
Journal:  Epilepsia       Date:  2014-01-21       Impact factor: 5.864

3.  Synergistic anticonvulsant effects of pregabalin and amlodipine on acute seizure model of epilepsy in mice.

Authors:  Itefaq Hussain Qureshi; Azra Riaz; Rafeeq Alam Khan; Afaq Ahmed Siddiqui
Journal:  Metab Brain Dis       Date:  2017-03-09       Impact factor: 3.584

Review 4.  Gene polymorphisms and their role in epilepsy treatment and prognosis.

Authors:  Ortrud K Steinlein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-16       Impact factor: 3.000

5.  Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome.

Authors:  John C Oakley; Alvin R Cho; Christine S Cheah; Todd Scheuer; William A Catterall
Journal:  J Pharmacol Exp Ther       Date:  2013-02-19       Impact factor: 4.030

6.  Myoloid-related protein 8, an endogenous ligand of Toll-like receptor 4, is involved in epileptogenesis of mesial temporal lobe epilepsy via activation of the nuclear factor-κB pathway in astrocytes.

Authors:  Na Gan; Lifen Yang; Ahmed Omran; Jing Peng; Liwen Wu; Fang He; Ciliu Zhang; Qiulian Xiang; Huimin Kong; Yupin Ma; Muhammad Usman Ashhab; Xiaolu Deng; Fei Yin
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

Review 7.  Selecting Rational Drug Combinations in Epilepsy.

Authors:  Bassel Abou-Khalil
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

8.  Astrocytes and Epilepsy.

Authors:  Devin K Binder; Christian Steinhäuser
Journal:  Neurochem Res       Date:  2021-03-04       Impact factor: 3.996

9.  Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures.

Authors:  Sarah Baxendale; Celia J Holdsworth; Paola L Meza Santoscoy; Michael R M Harrison; James Fox; Caroline A Parkin; Philip W Ingham; Vincent T Cunliffe
Journal:  Dis Model Mech       Date:  2012-06-21       Impact factor: 5.758

10.  Experimental re-evaluation of flunarizine as add-on antiepileptic therapy.

Authors:  Anamika Thakur; A K Sahai; J S Thakur
Journal:  J Pharm Bioallied Sci       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.